$167.26
arrow_drop_down1.31%Key Stats | |
---|---|
Open | $169.82 |
Prev. Close | $169.36 |
EPS | -1.76 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 163.20 | 174.95 |
52 Week Range | 36.90 | 174.95 |
Ratios | |
---|---|
EPS | -1.76 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
Liquid Biopsy Market to Reach $ 32.54 Billion, Globally, by 2033 at 11.61% CAGR: The Brainy Insights
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Laboratory-Developed Tests (LDTs) World Market Forecast Report to 2028, with Coverage of the Effects of the FDA's New "Medical Devices: Laboratory Developed Tests" Rule, Passed in April 2024
Natera executive sells shares worth over $57k - Investing.com
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?